Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

Clinical trial NCT04283539 · COMPLETED

Trial details

NCT number: NCT04283539
Sponsor: National Jewish Health
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer Skin Disease Immunotherapy Patients With Solid Tumors Receiving Immunotherapy With an ICI Will be Randomized to Participate in an SDoH and Side Effects Navigation Program vs. Control

Start date: 2020-09-23
Primary completion: 2025-03-25
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.